Sponsor or institution

Clinical trials and research at National Cancer Centre, Singapore

• 24Clinical trials
• 1New in 30 days
• 3Countries

Newest trials

All recruiting trials (24)

• AI chatbot to screen for hereditary cancer risk in Singaporeans

  A chat-based AI tool is being tested to see if it can quickly and reliably flag people who may have hereditary cancer risk.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT07901543

• CCC model to help serious illness conversations and care in cancer

  This trial tests a Communication and Care Coordinator (CCC) model to see if it can improve communication about serious illness and care planning for cancer patients.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT07733973

• Histotripsy treatment for small liver tumours in Asia

  This trial will try using histotripsy, a noninvasive focused-ultrasound treatment, to destroy small liver tumors in adults in Asia who are not candidates for surgery or other local therapies.

  Recruiting at 3 sites National Cancer Centre, Singapore · Singapore and 2 other locations · NCT07428356

• Aromatherapy for Mild Cognitive Impairment and Mild Dementia

  This study tests whether a diffused essential-oil blend for 6 months can help reduce symptoms for people with MCI or mild dementia and lessen caregiver stress.

  Recruiting at 2 sites National Cancer Centre, Singapore · Singapore and 1 other locations · NCT07234357

• Exercise plus cognitive behavioural therapy for fatigue in women treated for breast cancer in Singapore

  This program tests whether graded exercise combined with cognitive behavioural therapy can reduce fatigue and help women with breast cancer stay on their treatment plans.

  Recruiting at 4 sites National Cancer Centre, Singapore · Singapore and 3 other locations · NCT07116161

• iCareBreast+: a smartphone self-care app for women with breast cancer on chemotherapy

  This pilot tests whether iCareBreast+, a smartphone self-care app, helps women with stage 1–3 breast cancer who are starting chemotherapy feel more confident, informed, and better able to manage symptoms.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT06977360

• Assessing outcomes in patients with advanced solid tumors receiving non-standard therapies

  This study is testing how well non-standard treatments work for patients with advanced solid tumors by using personalized treatment plans based on their unique genetic profiles.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT06956248

• Using aromatherapy to reduce distress in breast cancer patients before radiotherapy

  This study is testing if breathing in scents from Asian plants can help breast cancer patients feel less anxious before their first radiotherapy session.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT06766058

• Intramuscular ACM-CpG treatment for advanced solid tumors

  This study is testing a new injection treatment for people with advanced solid tumors who have already tried immunotherapy to see if it is safe and effective.

  Recruiting Phase 1 National Cancer Centre, Singapore · Singapore · NCT06587295

• Database of advanced lung cancer patients with specific EGFR mutations in Asia

  This study is gathering information from around 600 patients with advanced lung cancer and specific EGFR mutations in Asia to see how these mutations affect their treatment outcomes.

  Recruiting at 3 sites National Cancer Centre, Singapore · Singapore and 2 other locations · NCT06418412

• Palliative care interventions for heart failure patients and their caregivers

  This study tests a new palliative care program for people with advanced heart failure and their caregivers to see if it can improve their quality of life and support their needs better.

  Recruiting at 4 sites National Cancer Centre, Singapore · Singapore and 3 other locations · NCT06244953

• Treatment for relapsed or refractory Peripheral T-Cell Lymphoma using Pembrolizumab and Olaparib

  This study is testing if a combination of two drugs, Pembrolizumab and Olaparib, can help people with relapsed or hard-to-treat Peripheral T-Cell Lymphoma feel better and live longer.

  Recruiting Phase 2 National Cancer Centre, Singapore · Singapore · NCT06160843

• Using Tislelizumab and Metronomic Capecitabine for High-risk Nasopharyngeal Carcinoma

  This study is testing if a combination of two treatments can help people with high-risk nasopharyngeal cancer who still have detectable Epstein-Barr virus after their initial chemotherapy stay cancer-free longer.

  Recruiting at 2 sites Phase 2 National Cancer Centre, Singapore · Singapore and 1 other locations · NCT06093061

• Proactive palliative care model for advanced cancer patients

  This study tests a new telehealth support program for advanced cancer patients and their caregivers to see if it helps them feel better and manage their care more effectively compared to regular treatment.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT06044441

• Exercise program for breast cancer patients

  This study tests whether a 24-week exercise program can improve fitness, strength, and quality of life for breast cancer patients who have finished their treatment.

  Recruiting at 3 sites National Cancer Centre, Singapore · Singapore and 2 other locations · NCT05957068

• Low dose chemotherapy for metastatic pancreatic cancer

  This study is testing a low dose combination of chemotherapy drugs to see if it can help people with metastatic pancreatic cancer feel better and manage their disease.

  Recruiting Phase 2 National Cancer Centre, Singapore · Singapore · NCT05929885

• Lung cancer screening using low-dose CT and biomarkers in Singapore

  This study is testing if low-dose CT scans and biomarker tests can help find lung cancer early in people aged 50-80 in Singapore who are at risk, including both smokers and non-smokers.

  Recruiting at 5 sites National Cancer Centre, Singapore · Singapore and 5 other locations · NCT05724264

• Personalized treatment for nasopharyngeal carcinoma based on EBV DNA levels

  This study is testing if tailoring chemotherapy for people with advanced nasopharyngeal carcinoma based on their EBV DNA levels can improve their chances of staying cancer-free.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT05517135

• Using multi-omics to predict treatment response in liver cancer patients

  This study is testing if a combination of two drugs can help liver cancer patients who have had surgery stay cancer-free longer by looking at their unique biological traits.

  Recruiting at 5 sites Phase 2 National Cancer Centre, Singapore · Singapore and 5 other locations · NCT05516628

• Predicting treatment for sarcomas and melanomas using patient-derived models

  This study is trying to see if creating models from tumor samples can help find the best drug combinations for patients with sarcomas and melanomas after their usual treatments haven't worked.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT04986748

• Neoantigen vaccine combined with nivolumab for liver cancer treatment

  This study is testing a personalized vaccine combined with a cancer drug to see if it can help people with liver cancer stay cancer-free after surgery.

  Recruiting Phase 2 National Cancer Centre, Singapore · Singapore · NCT04912765

• Comparing telegenetics and in-person genetic counselling

  This study is testing whether online genetic counseling is just as good and cost-effective as in-person counseling for patients considering genetic tests for hereditary breast and ovarian cancer and Lynch syndrome.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT04738708

• Identifying biomarkers for radiation sensitivity in cancer patients

  This study is trying to find out if certain blood and tissue markers can help predict how sensitive cancer patients are to radiation therapy, especially those who have had bad side effects.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT04340024

• Personalized cancer treatment based on tumor molecular profiling

  This study is testing whether analyzing the genetic makeup of a person's tumor can help doctors choose the best cancer treatment for them.

  Recruiting National Cancer Centre, Singapore · Singapore · NCT02806388

Quick answers

How many clinical trials run by National Cancer Centre, Singapore are recruiting right now?

24, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Singapore (24 trials), South Korea (1 trial), Taiwan (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →